Supplementary Figure 6 from Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2–WNT Signaling Axis
Srinivas Nandana(Samueli Institute), Leland W.K. Chung(VA Palo Alto Health Care System), Majd Zayzafoon(University of Alabama at Birmingham), Neil A. Bhowmick(Cedars-Sinai Medical Center), Renjie Jin(Vanderbilt University Medical Center), Hironobu Yamashita(Penn State Milton S. Hershey Medical Center), Peng Duan(Sun Yat-sen University), Rajeev Mishra, Robert J. Matusik(Vanderbilt University Medical Center), Chia-Yi Chu, Chunyan Liu(Cedars-Sinai Medical Center), Manisha Tripathi(Texas Tech University), Haiyen E. Zhau(Cedars-Sinai Medical Center)
Cited by 0
Related Papers
Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.
|PubMed|1994|739
Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers
|Angewandte Chemie International Edition|2011|618
Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry
|Nature Protocols|2007|520
Role of EMT in Metastasis and Therapy Resistance
|Journal of Clinical Medicine|2016|493